Poirier Michael S.
Insider CIK 1812504 · QLGN Chairman, President & CEO., Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2022-07-11 | 2022-08-04 | 375,000 | — | $0 | 375,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2022-06-22 | 2022-06-22 | 30,000 | $0.57 | $17.1K | 199,202 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2021-04-20 | 2021-04-21 | 11,005 | $1.80 | $19.8K | 11,005 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2020-06-06 | 2020-06-08 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 22,142 | — | $0 | 22,142 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 29,847 | — | $0 | 29,847 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 22,142 | — | $0 | 22,142 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 14,437 | — | $0 | 14,437 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other | 2020-05-22 | 2020-05-27 | 169,192 | — | $0 | 169,192 | SEC↗ |